Great Robotics, a Beijing-based medical robotics company, has reportedly raised close to RMB 100 million (USD 14.9 million) in a pre-Series A financing round. The round was led by INCE Capital, with participation from Orient Jiafu Asset Management. The proceeds will be used for testing and clinical studies of an orthopedic endoscopic master-slave minimally invasive full-process surgical robot and the development of a next-generation composite guided vascular intervention minimally invasive robot, among other products.
Company Profile
Great Robotics offers a platform solution that integrates precise intraoperative imaging, intelligent software, master-slave force-controlled multi-arm surgical robots, proprietary consumables, and more. The company is currently focusing on the development of an orthopedic endoscope master-slave control minimally invasive full-process surgical robot platform and a composite guided vascular intervention minimally invasive robot platform. These platforms are expected to enter clinical trials later this year and early next year, respectively.-Fineline Info & Tech
